NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

"The World’s First Brain Tumor Vaccine
Another breakthrough in brain tumor treatment is DCVax, which is the world’s first brain tumor vaccine. DCVax is produced by combining proteins from a patient’s own tumor with their white blood cells, effectively training the immune system to recognize and fight the cancer. The educated white blood cells help the rest of the immune system identify the tumor as a threat and mount an attack against it.

Although DCVax is not yet available on the National Health Service (NHS) in the United Kingdom, Northwest Biotherapeutics, the U.S. company behind the vaccine, plans to seek regulatory approval to make it more widely accessible. Brain Tumor Research, a charity organization, emphasizes the importance of making DCVax affordable and potentially a standard of care treatment. Glioblastoma patients have had limited new clinical options since the introduction of temozolomide chemotherapy in 2005."